Stephen J Weiss
E Gifford and Love Barnett Upjohn Professor of Internal Medicine and Oncology
Professor of Internal Medicine
Research Professor
Life Sciences Institute
Life Sciences Institute
210 Washtenaw
Ann Arbor, Mi 48109
[email protected]

Available to mentor

Stephen J Weiss
Research Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    I hold the Upjohn Chair in Medicine & Oncology at the University. I am a member of the Life Sciences Institute and have previously served as the Chief of Molecular Medicine in the Dept of Int Med, the interim Director of the Life Sciences Institute and the Assoc Director of Basic Science Research at the Rogel Cancer Center. I have no clinical or formal teaching responsibilities and confine all of my efforts to the my research program.

    Qualifications
    • Fellow
      University of Michigan, Internal Medicine, 1980
    • Intern/Resident
      Washington University in St. Louis School of Medicine, Pathology, 1978
    • MD
      Ohio State University, United States of America, 1977
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Rogel Cancer Center
    Research Overview

    Research interests focus on interactions between mesenchymal/skeletal stems as well as adipocytes and the surrounding extracellular matrix both in vitro and in vivo with particular emphasis on the role of mechanotransduction-linked pathways impacting nuclear transcription.

    Recent Publications See All Publications
    • Journal Article
      The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease.
      Fu J, Li S, Ma H, Yang J, Pagnotti GM, Brown LM, Weiss SJ, Mapara MY, Lentzsch S. Nat Commun, 2023 Jul 17; 14 (1): 4271 DOI:10.1038/s41467-023-39769-8
      PMID: 37460553
    • Journal Article
      11. Mesenchymal Lineage Discoidin Domain Receptor 2 Affects Heterotopic Ossification Formation and Extracellular Matrix Organization
      Pagani CA, Bancroft AC, Tower RJ, Livingston N, Sun Y, Hong JY, Nanes BA, Kent RN, Dean K, Franceschi R, Baker BM, Weiss SJ, Levi B. Plastic & Reconstructive Surgery Global Open, 11 (5S): 7 - 8. DOI:10.1097/01.gox.0000937640.56138.fb
    • Journal Article
      A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.
      Zhu L, Tang Y, Li X-Y, Kerk SA, Lyssiotis CA, Feng W, Sun X, Hespe GE, Wang Z, Stemmler MP, Brabletz S, Brabletz T, Keller ET, Ma J, Cho J-S, Yang J, Weiss SJ. EMBO J, 2023 Apr 3; 42 (7): e111148 DOI:10.15252/embj.2022111148
      PMID: 36843552
    • Journal Article
      Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.
      Zhu L, Tang Y, Li X-Y, Kerk SA, Lyssiotis CA, Sun X, Wang Z, Cho J-S, Ma J, Weiss SJ. J Cell Biol, 2023 Apr 3; 222 (4): DOI:10.1083/jcb.202206121
      PMID: 36880731
    • Journal Article
      Discoidin domain receptor 2 regulates aberrant mesenchymal lineage cell fate and matrix organization.
      Pagani CA, Bancroft AC, Tower RJ, Livingston N, Sun Y, Hong JY, Kent RN, Strong AL, Nunez JH, Medrano JMR, Patel N, Nanes BA, Dean KM, Li Z, Ge C, Baker BM, James AW, Weiss SJ, Franceschi RT, Levi B. Sci Adv, 2022 Dec 21; 8 (51): eabq6152 DOI:10.1126/sciadv.abq6152
      PMID: 36542719
    • Journal Article
      Divergent regulation of basement membrane trafficking by human macrophages and cancer cells.
      Bahr JC, Li X-Y, Feinberg TY, Jiang L, Weiss SJ. Nat Commun, 2022 Oct 27; 13 (1): 6409 DOI:10.1038/s41467-022-34087-x
      PMID: 36302921
    • Journal Article
      The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Cytoskeleton Regulation and Multiple Myeloma Bone Disease
      Fu J, Li S, Ma H, Yang J, Brown LM, Pagnotti GM, Weiss SJ, Mapara MY, Lentzsch S. Blood, 2022 Nov 15; 140 (Supplement 1): 9930 - 9932. DOI:10.1182/blood-2022-169921
    • Journal Article
      OAB-025: The role of checkpoint inhibitor PD-1H/VISTA in osteoclast activation and bone disease in multiple myeloma
      Fu J, Li S, Ma H, Yang J, Brown L, Pagnotti G, Weiss S, Mapara M, Lentzsch S. Clinical Lymphoma Myeloma & Leukemia, 2022 Aug; 22: s15 DOI:10.1016/s2152-2650(22)00298-1